2023 Q3 Form 10-Q Financial Statement

#000149315223028149 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $6.361K $2.836K
YoY Change 124.29%
Cost Of Revenue $4.685K $2.421K
YoY Change 93.52%
Gross Profit $1.676K $415.00
YoY Change 303.86%
Gross Profit Margin 26.35% 14.63%
Selling, General & Admin $46.98K $50.23K $288.5K
YoY Change -78.36% -82.59% -79.35%
% of Gross Profit 2997.02% 69518.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.600K $1.940K $1.710K
YoY Change -11.11% 13.45%
% of Gross Profit 115.75% 412.05%
Operating Expenses $46.98K $50.23K $290.2K
YoY Change -78.54% -82.69% -79.23%
Operating Profit -$46.98K -$48.56K -$289.8K
YoY Change -78.47% -83.25% -79.26%
Interest Expense -$32.53K -$317.5K $519.9K
YoY Change -107.13% -161.07% -112.86%
% of Operating Profit
Other Income/Expense, Net -$181.2K -$353.8K $501.5K
YoY Change -164.65% -170.54% -112.59%
Pretax Income -$228.2K -$402.3K $211.7K
YoY Change -467.42% -290.01% -103.93%
Income Tax
% Of Pretax Income
Net Earnings -$228.2K -$402.3K $211.7K
YoY Change -467.41% -290.01% -103.93%
Net Earnings / Revenue -6324.63% 7465.8%
Basic Earnings Per Share $0.00 -$0.01 $0.00
Diluted Earnings Per Share $0.00 -$0.01 $4.425K
COMMON SHARES
Basic Shares Outstanding 81.75M shares 76.66M shares 47.85M shares
Diluted Shares Outstanding 81.75M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $590.00 $2.260K $34.82K
YoY Change -99.79% -93.51% -96.43%
Cash & Equivalents $588.00 $2.260K $34.82K
Short-Term Investments
Other Short-Term Assets $720.0K $435.0K $14.55K
YoY Change 3575.34% 2889.69%
Inventory $100.9K $101.0K $266.2K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $941.5K $658.3K $315.5K
YoY Change 52.7% 108.62% -72.48%
LONG-TERM ASSETS
Property, Plant & Equipment $17.57K $19.17K $26.63K
YoY Change -29.23% -28.0% 26.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $100.00 $100.00 $100.00
YoY Change 0.0% 0.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $17.67K $19.27K $26.73K
YoY Change -29.12% -27.89% 26.3%
TOTAL ASSETS
Total Short-Term Assets $941.5K $658.3K $315.5K
Total Long-Term Assets $17.67K $19.27K $26.73K
Total Assets $959.1K $677.6K $342.3K
YoY Change 49.53% 97.96% -70.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $361.4K $298.4K $247.2K
YoY Change 14.77% 20.74% 101.77%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.228M $1.984M $2.504M
YoY Change 125.28% -20.76% 33.89%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.960M $2.777M $3.404M
YoY Change 108.58% -18.44% -45.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.960M $2.777M $3.404M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.960M $2.777M $3.404M
YoY Change 108.58% -18.44% -45.95%
SHAREHOLDERS EQUITY
Retained Earnings -$26.33M -$26.10M -$25.27M
YoY Change 4.45% 3.29%
Common Stock $8.284K $7.833K $4.784K
YoY Change 9.85% 63.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.001M -$2.099M -$3.062M
YoY Change
Total Liabilities & Shareholders Equity $959.1K $677.6K $342.3K
YoY Change 49.53% 97.96% -70.69%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$228.2K -$402.3K $211.7K
YoY Change -467.41% -290.01% -103.93%
Depreciation, Depletion And Amortization $1.600K $1.940K $1.710K
YoY Change -11.11% 13.45%
Cash From Operating Activities -$26.67K -$28.78K -$531.2K
YoY Change -94.29% -94.58% -37.08%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$285.0K -$435.0K
YoY Change
Cash From Investing Activities -$285.0K -$435.0K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 310.0K 465.0K 381.5K
YoY Change -56.17% 21.9% 54.39%
NET CHANGE
Cash From Operating Activities -26.67K -28.78K -531.2K
Cash From Investing Activities -285.0K -435.0K 0.000
Cash From Financing Activities 310.0K 465.0K 381.5K
Net Change In Cash -1.670K 1.220K -149.7K
YoY Change -100.7% -100.81% -74.96%
FREE CASH FLOW
Cash From Operating Activities -$26.67K -$28.78K -$531.2K
Capital Expenditures $0.00
Free Cash Flow -$531.2K
YoY Change -37.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000897078
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 KOAN Common Stock Issuable
CommonStockIssuable
usd
CY2022Q4 KOAN Common Stock Issuable
CommonStockIssuable
usd
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
usd
KOAN Non Cash Expenses Management Fees
NonCashExpensesManagementFees
usd
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
CY2023Q2 KOAN Gain Loss On Settlement Of Notes Payable
GainLossOnSettlementOfNotesPayable
usd
KOAN Gain Loss On Settlement Of Notes Payable
GainLossOnSettlementOfNotesPayable
usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
KOAN Non Cash Interest Expense
NonCashInterestExpense
usd
KOAN Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
usd
KOAN Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
usd
KOAN Stock Subscription Receivable
StockSubscriptionReceivable
usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
KOAN Proceeds From Subscription
ProceedsFromSubscription
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
usd
CY2023Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
usd
CY2022Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21202
dei Entity Registrant Name
EntityRegistrantName
Resonate Blends, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-1588291
dei Entity Address Address Line1
EntityAddressAddressLine1
26565 Agoura Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Calabasas
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91302
dei City Area Code
CityAreaCode
571
dei Local Phone Number
LocalPhoneNumber
888-0009
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81748596 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2260 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64419 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
101019 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
160492 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
120000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
150000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
435000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
658279 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
374911 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19172 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24110 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
100 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
100 usd
CY2023Q2 us-gaap Assets
Assets
677551 usd
CY2022Q4 us-gaap Assets
Assets
399121 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
298397 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
319618 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
70099 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
164946 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1527672 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
988800 usd
CY2023Q2 us-gaap Senior Notes Current
SeniorNotesCurrent
456305 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
424224 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
72487 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2776697 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1545851 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2776697 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1545851 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78328877 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78328877 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75437604 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75437604 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
7833 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7544 usd
CY2023Q2 KOAN Stocks Subscription Receivable
StocksSubscriptionReceivable
-261059 usd
CY2022Q4 KOAN Stocks Subscription Receivable
StocksSubscriptionReceivable
-261059 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24257566 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24427009 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26103686 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25320424 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2099146 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1146730 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
677551 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
399121 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6361 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2836 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16468 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30488 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
4685 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2421 usd
us-gaap Cost Of Revenue
CostOfRevenue
13257 usd
us-gaap Cost Of Revenue
CostOfRevenue
15278 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1676 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
415 usd
us-gaap Gross Profit
GrossProfit
3211 usd
us-gaap Gross Profit
GrossProfit
15210 usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
153 usd
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
69806 usd
us-gaap Advertising Expense
AdvertisingExpense
13437 usd
us-gaap Advertising Expense
AdvertisingExpense
235277 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24263 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
78987 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
91435 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106503 usd
CY2023Q2 KOAN Legal And Professional Fees
LegalAndProfessionalFees
25815 usd
CY2022Q2 KOAN Legal And Professional Fees
LegalAndProfessionalFees
47663 usd
KOAN Legal And Professional Fees
LegalAndProfessionalFees
38780 usd
KOAN Legal And Professional Fees
LegalAndProfessionalFees
73338 usd
CY2022Q2 us-gaap Officers Compensation
OfficersCompensation
89250 usd
us-gaap Officers Compensation
OfficersCompensation
5000 usd
us-gaap Officers Compensation
OfficersCompensation
324250 usd
CY2022Q2 KOAN Non Cash Expenses Management Fees
NonCashExpensesManagementFees
4505 usd
KOAN Non Cash Expenses Management Fees
NonCashExpensesManagementFees
206462 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
50231 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
290211 usd
us-gaap Operating Expenses
OperatingExpenses
148652 usd
us-gaap Operating Expenses
OperatingExpenses
945830 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48555 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-289796 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-145441 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-930620 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
105706 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
344 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
152109 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
22801 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-211786 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
520273 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-351737 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1687112 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36263 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
133975 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
31795 usd
CY2022Q2 KOAN Gain Loss On Settlement Of Notes Payable
GainLossOnSettlementOfNotesPayable
-18403 usd
KOAN Gain Loss On Settlement Of Notes Payable
GainLossOnSettlementOfNotesPayable
-126 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-353755 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
501526 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-637821 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1632390 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-402310 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
211730 usd
us-gaap Net Income Loss
NetIncomeLoss
-783262 usd
us-gaap Net Income Loss
NetIncomeLoss
701770 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76480707 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47846859 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75962037 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47846859 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4101931 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
131525 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
202047 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
490040 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3278319 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4505 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
211730 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3062084 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1146730 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1146730 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-247142 usd
CY2023Q1 KOAN Stock Issued During Period Value Exercise Of Warrant
StockIssuedDuringPeriodValueExerciseOfWarrant
6000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-380952 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1768824 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1768824 usd
CY2023Q2 KOAN Stock Issued During Period Value Exercise Of Warrant
StockIssuedDuringPeriodValueExerciseOfWarrant
24000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2303 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
45685 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-402310 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-402310 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2099146 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2099146 usd
us-gaap Net Income Loss
NetIncomeLoss
-783262 usd
us-gaap Net Income Loss
NetIncomeLoss
701770 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-351737 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1687112 usd
KOAN Non Cash Interest Expense
NonCashInterestExpense
133975 usd
KOAN Share Professional Fees Compensation
ShareProfessionalFeesCompensation
47988 usd
KOAN Share Professional Fees Compensation
ShareProfessionalFeesCompensation
206462 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4938 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4711 usd
KOAN Stock Subscription Receivable
StockSubscriptionReceivable
-261059 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-59473 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20396 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
3721 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-30000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
271639 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
40281 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
9500 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
116488 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1009564 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
435000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-435000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
460000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
788800 usd
KOAN Proceeds From Subscription
ProceedsFromSubscription
392674 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
94847 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
138800 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
150000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
256353 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1031474 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62159 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21910 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
64419 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12913 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2260 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34823 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
150000 usd
CY2013Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The Company also voted to approve a 1 for 5 reverse split of its outstanding common stock.
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26103686 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zdBrOb8f1Py6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zQWn2huyOEA1">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
424224 usd
CY2022Q4 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
72487 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1540000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
988800 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
12328 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1527672 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
988800 usd
KOAN Property And Equipment Excess Capitalized Cost
PropertyAndEquipmentExcessCapitalizedCost
1000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.030
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.73 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.20 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0464 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0145 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2019Q4 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company signed a lease agreement that expires on thirty days’ notice. Rent expense was approximately $7,539 and $2,502 for the six months ended June 30, 2023 and 2022, respectively
us-gaap Payments For Rent
PaymentsForRent
7539 usd
us-gaap Payments For Rent
PaymentsForRent
2502 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30000 usd

Files In Submission

Name View Source Status
R16.htm Edgar Link pending
0001493152-23-028149-index-headers.html Edgar Link pending
0001493152-23-028149-index.html Edgar Link pending
0001493152-23-028149.txt Edgar Link pending
0001493152-23-028149-xbrl.zip Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
koan-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
koan-20230630_def.xml Edgar Link unprocessable
koan-20230630_cal.xml Edgar Link unprocessable
koan-20230630_lab.xml Edgar Link unprocessable
koan-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending